Project Grant R01DA053296
Award Date
5/15/21
Completion Date
2/28/26
Dollars Obligated
$528K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award, with ID R01DA060250, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,447,919 award, granted on May 1, 2025, supports research conducted by Pennsylvania State University's Milton S. Hershey Medical Center to investigate the "need-state hypothesis" of cocaine addiction. The research aims to use an animal model to track the development of cocaine addiction, identify the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $438,750 to the University of California, San Diego (UCSD) to investigate pre-existing differences in GABAergic and glutamatergic transmission within the central amygdala and their potential contribution to individual differences in cocaine addiction susceptibility. The study aims to characterize and compare basal GABAergic and...
This federal Project Grant award of $440,000.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research into the G protein-coupled receptor GPR6 as a potential therapeutic target for cocaine use disorder. The University of Texas Medical Branch at Galveston (UTMB) will investigate GPR6 expression in specific neuronal populations, its status following cocaine self-administration, and the therapeutic potential of GPR6...
This $149,284 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to Vanderbilt University will fund research to understand how chronic cocaine use disrupts the neural processing of aversive, non-drug stimuli in the brain. The study aims to define the precise temporal parameters under which dopamine release modulates the activity of genetically-defined neuron populations in the nucleus accumbens, both at baseline and in...
This federal Project Grant award of $180,606.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is funding research to investigate cocaine-induced proteomic adaptations in the nucleus accumbens region of the brain. The principal investigator will use a combination of behavioral, cellular/molecular, and bioinformatic approaches to characterize the cell-type and circuit-specific synaptic proteome changes in response to cocaine...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $118,656 Project Grant to the Ponce Medical School Foundation Inc. (doing business as Ponce School of Medicine) in Puerto Rico. The grant, awarded on November 29, 2024, supports research to investigate the influence of fear conditioning and cocaine exposure on cocaine-seeking behavior in male and female rats. The project aims to analyze the synaptic changes in the...
This Project Grant award of $1,159,396 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at Vanderbilt University on the molecular and epigenetic mechanisms underlying how cocaine exposure activates specific neuronal ensembles in the nucleus accumbens and how these ensembles change over time to drive addiction-related behaviors. The research aims to use innovative techniques like single-nucleus RNA sequencing and...
This five-year, $573,638 project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, supports research into the neural mechanisms of individual differences in cocaine avoidance. Funded under the Drug Abuse and Addiction Research Programs (CFDA 93.279), the grant to the Medical University of South Carolina will examine cellular mechanisms by which serotonin and glutamate receptors in the rostromedial tegmental nucleus drive aversive conditioning...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,996,709.00 to the Trustees of Indiana University, doing business as Indiana University Indianapolis, for a project titled "Involvement of Cortical Excitatory Projections in Cocaine Addiction." The project aims to investigate the role of cortical pyramidal neurons in the supplementary motor cortex and their impact on glutamate...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to characterize the functions of several transcript variants of the DRD3 gene, which encodes the dopamine D3 receptor, and their roles in regulating cocaine-seeking and taking behavior. The $189,644 award to Wake Forest University Health Sciences will fund two phases of research. In the initial R21 phase, the researchers...